Impact of Impaired Fasting Glucose on Cardiovascular Disease
نویسندگان
چکیده
Methods Framingham offspring participants free of CVD, categorized by the 1997 ADA IFG definition (fasting plasma glucose 110 to 125 mg/dl; 6.1 to 6.9 mmol/l) or the 2003 definition (100 to 125 mg/dl; 5.6 to 6.9 mmol/l), were followed from 1983 to 2004. Pooled logistic regression was used to calculate multivariable-adjusted odds ratios (ORs) for incident coronary heart disease (CHD; 291 events) or CVD (423 events).
منابع مشابه
شیوع دیابت قندی نوع 2 و اختلال تحمل گلوکز درافراد 30 تا 64 ساله شهر بوشهر برپایه معیارهای سازمان جهانی سلامت و انجمن دیابت آمریکا
Introduction: The prevalence of type 2 diabetes is increasing daily all around the world and is a serious threat to the well-being of the community in terms of renal failure, cardiovascular disease, blindness, and neuropathy. The assessment of difference screening approaches is of great importance in this disease. We compared ADA and WHO criteria for the diagnosis of type 2 diabetes. Methods...
متن کاملPrehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study.
There are few data about the impact of the recently-defined category of prehypertension (systolic blood pressure 120 to 139 mm Hg or diastolic blood pressure 80 to 89 mm Hg) on cardiovascular disease incidence. It is also unknown whether this association differs between individuals with or without diabetes. A total of 2629 Strong Heart Study participants free from hypertension and cardiovascula...
متن کاملImpaired fasting glucose, blood pressure and cardiovascular disease mortality.
Impaired fasting glucose (fasting plasma glucose 6.1 to 6.9 mmol/L [110 to 125 mg/dL]) is a common glycemic disorder which usually progress to diabetes mellitus. The relationships between impaired fasting glucose, other risk factors including blood pressure, and mortality have never been clearly investigated. We studied 63 443 consecutive men (ages 21 to 60 years), each of whom had a routine he...
متن کاملImpaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
Type 2 Diabetes Mellitus tends to increase year by year and it has a high morbidity and mortality, especially among those who have macro-vascular complication(s) as cardiovascular disease. There are many prevention efforts that have been done, especially primary prevention i.e. prevention of Type 2 Diabetes Mellitus development. Impaired Glucose Tolerance (IGT) and Imparied Fasting Gycaemia (IF...
متن کاملThe Levels of Serum High Sensitivity C-reactive Protein in Subjects with Impaired Fasting Glucose
High-sensitivity C-reactive protein is a well-known risk factor for cardiovascular heart diseases. In this study we aimed to determine the levels of serum high-sensitivity Creactive protein in patients with newly diagnosed type diabetes mellitus and impaired fasting glucose, and to obtain clinical results by comparing impaired fasting glucose group with type 2 diabetes mellitus and normal group...
متن کاملAssociation of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study
BACKGROUND Pre-diabetes and untreated diabetes are common in patients with peripheral artery disease however their impact on outcome has not been evaluated. We examined the association of impaired fasting glucose, diabetes and their treatment with the presentation, mortality and requirement for intervention in peripheral artery disease patients. METHODS We prospectively recruited 1637 patient...
متن کامل